Cabazitaxel was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a semi-synthetic derivative of a natural taxoid. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.. Reference standards of Cabazitaxel API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => (2'S,3'R)-Cabazitaxel [catalogue_number] => PA 03 01550 [category_ids] => 82,80,79,78,74,70,69 [chemical_name] => [weight] => 835.93 [form] => C45H57NO14 [cas] => 1714967-27-7 [pslug] => 1714967-27-7-2s-3r-cabazitaxel-pa0301550 [latest_product] => 0 [linkproducts] => 0 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 34307 [offers_product_code] => PA 03 01550 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 03 01550
CAS :
Molecular Formula : C45H57NO14
Molecular Weight : 835.93
stdClass Object ( [pname] => Cabazitaxel N-formyl Impurity [catalogue_number] => PA 03 01530 [category_ids] => ,78,80,79,71,75, [chemical_name] => [weight] => 763.83 [form] => C41H49NO13 [cas] => NA [pslug] => cabazitaxel-n-formyl-impurity-pa0301530 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 03 01530
Molecular Formula : C41H49NO13
Molecular Weight : 763.83
stdClass Object ( [pname] => (2'S, 3'R)-Cabazitaxel-D6 [catalogue_number] => PA STI 016880 [category_ids] => ,79,80,69,74,78,70,82,98, [chemical_name] => [weight] => 841.97 [form] => C45H51D6NO14 [cas] => NA [pslug] => 2s-3r-cabazitaxel-d6-pasti016880 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 016880
Molecular Formula : C45H51D6NO14
Molecular Weight : 841.97
stdClass Object ( [pname] => 4-Deacetyl-4-propionyl Cabazitaxel-D6 [catalogue_number] => PA STI 024550 [category_ids] => ,79,80,69,74,78,70,82,98, [chemical_name] => [weight] => 856.00 [form] => C46H53D6NO14 [cas] => NA [pslug] => 4-deacetyl-4-propionyl-cabazitaxel-d6-pasti024550 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 024550
Molecular Formula : C46H53D6NO14
Molecular Weight : 856.00
stdClass Object ( [pname] => Cabazitaxel - Impurity G [catalogue_number] => PA 04 97670 [category_ids] => 69,70,74,78,79,80,82 [chemical_name] => [weight] => 1085.21 [form] => C58H72N2O18 [cas] => NA [pslug] => cabazitaxel-impurity-g-pa0497670 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 04 97670
Molecular Formula : C58H72N2O18
Molecular Weight : 1085.21
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
